Digitizing Health Care
Market Access Strategy
Mobilizing the Market
Developing people and organizations
Medical Technology and Biotechnology
EU5: Commercial assessment of a licensed product for the five major EU markets
Conception of the German market access for two innovatice products
Consistent brand management strengthens the clients base for health delivery
Corporate vision: long-term vision of a hospital
Digital strategy and agenda combine digitalization initiatives
Discharge management of a rare disease
How integrated care can be really effective
Service cost management: Limiting rising hospital spending
Strategic support and negotiation management:
Leadership strategy and executives development
Trail regulations: strategic support (according to §137e SGB V)
Value assessment and value story for a digital solution
Written statement and oral hearing revise the initial benefit assessment
Vision and Approach
Prof. Matthias P. Schönermark M.D., Ph.D.
Heike Kielhorn-Schönermark, MBA
Would you like to call us?
+49 511 64 68 14 0 – 0
Would you like to visit us personally?
This is how you find our office in Hannover.
Your request via contact form
* mandatory field
Yes, I agree with the
Discover the latest news from the industry, clearly and comprehensibly presented.
News from the implementation of a uniform EU-
FDA and EMA intensify international cooperation on ATMPs and Orphan Drugs
Corona virus and state intervention in the market - the connection
Successful market access for gene therapies version 2.0 – exclusive …
Health data in research and care – no progress without access
Amendments in the G-BA's Rules of Procedure reduce previous scope for …
Blog II of the Digital Health series: The most important requirements, …
The current status of the Medical Devices Regulation
to the top